Evaluating the Safety and Efficacy of the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE for Treatment of Acute Pulmonary Embolism
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 122 participants.
Also called NCT05318092
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 122 participants
- Sponsor
- Registry
-
NCT05318092
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT05318092. Allocation not applicable; no masking; primary purpose treatment. Start 2022-10-19 (actual); primary completion 2024-01-04 (actual). Results posted on 2024-07-19.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluating the Safety and Efficacy of the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE for Treatment of Acute Pulmonary Embolism
- Acronym
- APEX-AV
- Condition
- Pulmonary Embolism
- Condition
- Acute Pulmonary Embolism
- Intervention (Device)
- AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE
- Lead sponsor
- Angiodynamics, Inc.
Record details
- Record id
cardio:ct-nct05318092- Content hash
ceca2e2d5aa42ec87f9c9a30154e308c6d818b01231d172940352c125f040ea2